FDA Inspection 1045177 — NuCare Pharmaceuticals Inc

NuCare Pharmaceuticals Inc — FEI 3003294404

The FDA completed an inspection of NuCare Pharmaceuticals Inc on March 21, 2018 in Orange, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 21, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Orange, CA (United States)

Citations

IDCFRDescription
360321 CFR 211.160(b)Scientifically sound laboratory controls